Advertisement

Topics

Bavarian Nordic Research Institute A/S Company Profile

04:11 EST 24th November 2017 | BioPortfolio

Bavarian Nordic is a commercially viable international biopharmaceutical company through:

Biopharmaceutical innovations

Novel prophylactic and therapeutic approaches

Development, production, testing and marketing of novel pharmaceutical products.

Focusing on safe and efficient biopharmaceutical approaches

Development of a platform technology for use against multiple infectious and cancer diseases

Strong alliances with research partners worldwide.

Operations in several countries.

Location

Vesterbrogade 149
Copenhagen V
DK-1620
Denmark

Contact

Phone: 33 26 8383
Fax: 33 26 8380
Email: pw@bovarian-nordic.dk


News Articles [1385 Associated News Articles listed on BioPortfolio]

Bavarian Nordic A/S: Bavarian Nordic to Host First Half 2017 Results Conference Call

COPENHAGEN, Denmark - August 18, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2017 first half results on Friday, August 25, 2017. The management of Bavarian Nordic will hos...

Bavarian Nordic A/S: Independent Data Monitoring Committee Recommends Discontinuation of Bavarian Nordic's Phase 3 Study of PROSTVAC in Metastatic Prostate Cancer

Conference call scheduled for 2:00 PM CEST / 8:00 AM EDT tomorrow, Friday, September 15 COPENHAGEN, Denmark, September 14, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that a...

Bavarian Nordic seals $539 million vaccine deal

Bavarian Nordic, a Danish biotech, has continued its partnership with the US government by agreeing a $539 million deal to deliver smallpox vaccines. The partnership between Bavarian Nordic will see i...

Bavarian Nordic A/S: Bavarian Nordic Announces Exercise of Clinical Option by the US Government under Contract for Freeze-dried IMVAMUNE Smallpox Vaccine

Award of approximately USD 37 million will support clinical work required for product approval COPENHAGEN, Denmark, November 21, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today ...

JJDC buys $33mm in Bavarian Nordic equity

Johnson & Johnson Development Corp. purchased $32.8mm (DKK207.5mm) new Bavarian Nordic AS stock in a private placement of 512,102 shares priced at $64.18. The financing is part of a concurrent deal be...

Janssen and Bavarian Nordic sign $836m deal on Hep B and HIV vaccines

Janssen has signed a new deal with Bavarian Nordic worth up to $836 million to develop target vaccines for hepatitis B and HIV. The projects will combine Bavarian Nordic’s MVA-BN technology with Ja...

Bavarian Nordic A/S: Bavarian Nordic to Host Capital Markets Day in New York City

COPENHAGEN, Denmark, September 14, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will host a capital markets day for institutional investors and equity analysts on Thursday, September 21, 201...

Bavarian Nordic A/S: Bavarian Nordic Announces First Half 2017 Results

COPENHAGEN, Denmark, August 25, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results for the first half of 2017 and releases its financial calendar for ...

Drugs and Medications [116 Associated Drugs and Medications listed on BioPortfolio]

La mer the treatment fluid foundation [MAX HUBER RESEARCH LAB INC]

Alco-san instant skin sanitizer [Mid-American Chemical Research Corporation]

ALCO-SAN INSTANT SKIN SANITIZER

Korres quercetin 7 oak hydrating antiageing and antiwrinkle [Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc.]

Korres Quercetin & Oak Day Cream for Normal to Dry Skin SPF 4

Fareston [GTx, Inc.]

These highlights do not include all the information needed to use FARESTON® safely and effectively. See full prescribing information for FARESTON®.FARESTON® (toremifene citrate) 60 mg Tablets oral ...

Sunscreen [CRC (Cosmoceutical Research Center)]

SUNSCREEN SPF 28/30

PubMed Articles [1317 Associated PubMed Articles listed on BioPortfolio]

Estimating Usual Intake in the 2nd Bavarian Food Consumption Survey: Comparison of the Results Derived by the National Cancer Institute Method and a Basic Individual Means Approach.

The valid estimation of the usual dietary intake remains a challenge till date. We applied the method suggested by the National Cancer Institute (NCI) to data from the 2nd Bavarian Food Consumption Su...

eHealth provides a novel opportunity to exploit the advantages of the Nordic countries in psychiatric genetic research, building on the public health care system, biobanks, and registries.

Nordic countries have played an important role in the recent progress in psychiatric genetics, both with large well-characterized samples and expertise. The Nordic countries have research advantages d...

A History of the Western Institute of Nursing and Its Communicating Nursing Research Conferences.

The Western Institute of Nursing (WIN) celebrated its 60th anniversary and the 50th Annual Communicating Nursing Research Conference in April 2017.

A rapid LC-MS/MS method for the determination of moniliformin and occurrence of this mycotoxin in maize products from the Bavarian market.

A simple LC-MS/MS method was developed for the determination of moniliformin (MON) in maize and applied for the analysis of samples within the official food surveillance. The homogenized samples were ...

Cell scientist to watch - Paul Timpson.

Paul Timpson received his bachelor's degree from the University of Strathclyde, UK and completed his PhD under the supervision of Margaret Frame at the Beatson Institute for Cancer Research and the Un...

Clinical Trials [1508 Associated Clinical Trials listed on BioPortfolio]

Nordic Walking and Chronic Low Back Pain

This is a randimized clinical trial comparing the effect of supervised Nordic walking versus unsupervised Nordic walking versus advice to stay active

Healthy Nordic Foods to Prevent Cardiometabolic Risk in Obese Subjects

This project will examine whether long-term consumption of healthy Nordic foods can maintain a healthy weight also after weight loss, and decrease abdominal fat accumulation and cardiometa...

Eisenmenger Syndrome in the Nordic Countries

This is a historical cohort study with retrospective collection of data comprising all Nordic patient's diagnosed with Eisenmengers syndrome in the period 1977 through 2011. The goal is to...

WS®1442 in Slightly Overweight Subjects

The purpose of this study is to test: 1. Safety of 900 mg or 1800 mg of WS® 1442 per day in overweight subjects (BMI 25 to 29,9 kg/m²) 2. Pharmacodynamic effect of WS® ...

Nordic Hamstring and Repeated-sprint Ability in Football (Soccer) Players

The purpose of the study is to investigate the efficacy of a 10-week intervention, using the Nordic Hamstring exercise, on repeated-sprint ability in male sub-elite football players. The p...

Companies [2240 Associated Companies listed on BioPortfolio]

Bavarian Nordic

Bavarian Nordic initiated the development of IMVAMUNE® in 1999 and began the first clinical study in 2001. In 2003, Bavarian Nordic was awarded a contract, valued at $29 million, from the U.S. Natio...

Bavarian Nordic Research Institute A/S

Bavarian Nordic is a commercially viable international biopharmaceutical company through:Biopharmaceutical innovations Novel prophylactic and therapeutic approaches Development, production, testing an...

Bavarian Nordic A/S

In 2004 we marked our 10 year anniversary as a company. Over the past decade we have developed the early MVA vector research into a broad commercial vaccine vector technology.

Alliance for Biosecurity

The Alliance for Biosecurity was formed in June of 2005 by biopharmaceutical companies and the Center for Biosecurity of the University of Pittsburgh Medical Center. Alliance members are committed to...

Institute of Marine Research

The Institute of Marine Research is a national consultative research institute which is owned by the Ministry of Fisheries and Coastal Affairs. The Institute performs research and provides advisory se...

More Information about "Bavarian Nordic Research Institute A/S" on BioPortfolio

We have published hundreds of Bavarian Nordic Research Institute A/S news stories on BioPortfolio along with dozens of Bavarian Nordic Research Institute A/S Clinical Trials and PubMed Articles about Bavarian Nordic Research Institute A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bavarian Nordic Research Institute A/S Companies in our database. You can also find out about relevant Bavarian Nordic Research Institute A/S Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record